ProSolv is a well known provider of advanced medical software technologies, including its Cardiology-PACS (Picture Archiving and Communications System) that has been installed at approximately 350 sites in the U.S. and other parts of the world.
According to a press release, the transaction is part of Fujifilm’s global expansion of its medial imaging business, which has become one of the core businesses of the company. Fujifilm has earned global recognition for developing the digital x-ray imaging diagnostic system FCR in 1981, and subsequentliy its Web-integrated PACS, Synapse network system to store and process medical imaging information. More than 1,000 health care facilities around the world have installed Synapse, which will now be integrated with ProSolv’s cardiology-PACS. Fujifilm will introduce the integrated Synapse to cardiology departments and facilities worldwide that require solutions for the exchange of information sharing between radiology and cardiology departments.
Separately, Fujifilm has announced that its subsidiary Daiichi Radioisotope Laboratories Ltd. will be renamed Fujifilm RI Pharma Co. Ltd., effective April 1, 2007. According to a press release, the new company name indicates the company’s identity as a member of the Fujifilm Group and its business field of radiopharmaceuticals.